Clinical Trials Directory

Trials / Unknown

UnknownNCT04130373

Multicentric Risk Evaluation of Autologous Fat Grafting Procedure

Multicentic Retrospective Evaluation of Risks in Mammary Carcinoma Relapse in Patients With Mammary Reconstruction and Autologous Fat Grafting

Status
Unknown
Phase
Study type
Observational
Enrollment
6,510 (actual)
Sponsor
Humanitas Clinical and Research Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Autologous fat grafting, also known as lipofilling, is a surgical technique consisting in the processing and transfer of adipose tissue from one area in our organism (hips, thighs) to region which in need of reconstructive and aesthetic correction. The technique is frequently used after radical or conservative mammary surgery, aiming to achieve better aesthetic results, reduce pain induced by both surgery and radiotherapy. The scientific community was widely involved in the debate regarding the use of mesenchymal/stem cells in a patient with high risk of tumor progression due to their elevated proliferative profile. This study aims to retrospectively evaluate the oncological safety in the use of lipofilling in patients who underwent oncological and reconstructive treatment in our Institute.

Conditions

Interventions

TypeNameDescription
PROCEDUREAutologous fat grafting procedureSurgical intervention based on the injection of autologous fat grafting after radical or conservative breast surgery and breast reconstruction.
PROCEDUREBreast reconstructionBreast reconstructive procedures after oncological radical or conservative breast surgery

Timeline

Start date
2019-06-01
Primary completion
2020-01-01
Completion
2020-06-01
First posted
2019-10-17
Last updated
2019-10-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04130373. Inclusion in this directory is not an endorsement.

Multicentric Risk Evaluation of Autologous Fat Grafting Procedure (NCT04130373) · Clinical Trials Directory